Mid-cap pharmaceutical stocks are seen gaining this week while large-caps are expected to trade in a narrow range due to lack of any major positive trigger. Most mid-cap stocks have been flat for the past few weeks and should have a good run this week. In case of large-cap stocks, most of them had a rally this week, they are expected to be range-bound this week with a negative bias. Among mid-cap stocks, Ajanta Pharma, Jubilant Life Sciences, Shasun Pharmaceuticals, and Torrent Pharmaceuticals look positive for this week.
Investor sentiment in the Shasun Pharma counter is seen positive as the company is expected to bag an overseas contract this week. In large-caps, Ranbaxy Laboratories Ltd may rise ahead of the launch of its anti-diabetic drug Diovan later this month. Talking about Lupin, he said the management looks upbeat at present, which is very positive for investors. Panacea Biotec yesterday said it would Tuesday announce a strategic collaboration with US-based Osmotica Pharmaceuticals.
www.rupeedesk.in